Kaya-Yasar, Y. Et Al. 2024. The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide. DRUG DEVELOPMENT RESEARCH , vol.85, no.2 .

Kaya-Yasar, Y., Engin, S., Barut, E. N., Inan, C., Saygin, İ., Erkoseoglu, I., ... Sezen, S. F.(2024). The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide. DRUG DEVELOPMENT RESEARCH , vol.85, no.2.

Kaya-Yasar, Yesim Et Al. "The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide," DRUG DEVELOPMENT RESEARCH , vol.85, no.2, 2024

Kaya-Yasar, Yesim Et Al. "The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide." DRUG DEVELOPMENT RESEARCH , vol.85, no.2, 2024

Kaya-Yasar, Y. Et Al. (2024) . "The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide." DRUG DEVELOPMENT RESEARCH , vol.85, no.2.

@article{article, author={Yesim Kaya-Yasar Et Al. }, title={The contribution of the WNT pathway to the therapeutic effects of montelukast in experimental murine airway inflammation induced by ovalbumin and lipopolysaccharide}, journal={DRUG DEVELOPMENT RESEARCH}, year=2024}